ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,661, issued on Aug. 11, was assigned to Noema Pharma AG (Basel, Switzerland).
"Methods of preparing matrix pellet compositions" was invented by George Garibaldi (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating tuberous sclerosis complex in a subject in need thereof by administering to the subject compositions comprising an mGlu5 negative allosteric modulator (NAM), having the structure of Formula I:"
The patent was filed on April 22, 2024, under Application No. 18/641,640.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?...